Nature Reviews Endocrinology

Papers
(The median citation count of Nature Reviews Endocrinology is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-02-01 to 2025-02-01.)
ArticleCitations
The largest study of genetics of T1DM419
Urban built environments: interventions for reducing cardiometabolic risks397
A protective role for insulin in acute pancreatitis396
Comorbidities of excess adiposity — a genetic link392
Nonenzymatic prevention of insulin hyperresponsiveness by FBP1293
The discovery of human monogenic obesity268
Reply to ‘Paracetamol use in pregnancy — neglecting context promotes misinterpretation’267
Increasing success of islet transplantation259
Diagnosis of gestational diabetes mellitus: the debate continues235
CNOT6L regulates hepatokine expression233
Strategies for modelling endometrial diseases213
Effects of pancreatic SARS-CoV-2 infection identified212
FAPs linked with muscle degeneration in T2DM198
Glycogen involved in browning of adipocytes183
Ageing immune cells reduce adipose tissue function178
On the cutting edge: perspectives in bioenergetics171
A role for circulating levels of uridine in regulating hunger and food intake168
Aster pathway maintains hepatic cholesterol homeostasis130
The relationship between the gut microbiota and thyroid disorders125
Exercise-induced plasma factors confer brain benefits120
Fetal orchestration of maternal metabolism via IGF2112
Caution needed: paracetamol use in pregnancy109
Is combined exercise and incretin-based therapy the way forward for weight-loss maintenance?109
Paracetamol use in pregnancy — caution over causal inference from available data108
Differences in stem cell-derived islets105
Harnessing the inflammatory processes in endometriosis102
Ghrelin’s effects on growth hormone release: to pulse or not to pulse?102
Dexamethasone in patients with diabetes mellitus101
Phase IIa results for potential NAFLD therapy94
GLP1-mediated delivery of tesaglitazar improves glucose metabolism in mice92
Interventions in people newly diagnosed with type 1 diabetes mellitus91
Exposing skin to ultraviolet irradiation increases food intake in male individuals91
Origins of the ‘KNDy hypothesis’ of GnRH pulse generation89
A century of glucagon87
The ATP-binding cassette proteins ABCB1 and ABCC1 as modulators of glucocorticoid action85
Co-agonist therapeutics come of age for obesity80
Mitochondria transported from adipocytes in extracellular vesicles77
Obesity-associated ASB4 controls satiety77
Nutrient regulation of bone marrow adipose tissue: skeletal implications of weight loss76
Medically not yet explained symptoms in hypothyroidism76
The role of DNA damage in diabetic complications75
Effects of diet on atherosclerotic plaque development74
Uncovering how the GnRH pulse generator is controlled in female mice73
Non-nutritive sweeteners — too sweet to be wholesome?73
Unravelling the molecular basis of futile creatine cycling68
Timed high-fat diet feeding restores small bowel circadian rhythms68
Approaches to addressing the rise in obesity levels67
Adipose tissue lipolysis controlled by endothelial cells66
A mitochondrial trigger for beige adipocyte development65
Thyroid-function reference ranges in the diagnosis of thyroid dysfunction in adults63
Immune cell population prevents weight regain61
The influence of the circulatory system on tissue ageing: does the fountain of youth lie in our blood?61
GWAS gives insights into glucose regulation61
Non-invasive daily profiles of tissue adrenal steroids60
SGLT inhibitors: a serendipitous glycaemic tale60
Bile acid species shows potential for NAFLD60
Thyroid function and iodine intake: global recommendations and relevant dietary trends59
Low brown adipose tissue activity linked to NAFLD59
Do psychedelics have therapeutic potential for obesity?57
New insights on regulatory T cell decline in obesity57
Statins and diabetes mellitus progression: a fly in the ointment?54
The individual response to antibiotics and diet — insights into gut microbial resilience and host metabolism54
Identification of thermogenic adipocyte lineages53
New genes associated with adult-onset obesity52
Phospholipid biosynthetic pathways and lipodystrophies: a novel syndrome due to PLAAT3 deficiency50
TIM4+ adipose tissue-resident macrophages: new modulators of adiposity48
Lactate as a major myokine and exerkine47
Obesity-induced and weight-loss-induced physiological factors affecting weight regain45
PPAR mediates intestinal stem cell tumorigenesis44
The regulation of endocrine-disrupting chemicals to minimize their impact on health42
Brown adipose tissue fights the battle against leukaemia40
CITED1 mediates sex-specific regulation of food intake in hypothalamic neurons40
The challenges of assessing adiposity in a clinical setting40
The gut microbiota in obesity and weight management: microbes as friends or foe?37
The complexity of adipocyte heterogeneity37
International consensus guidelines on the implementation and monitoring of vosoritide therapy in individuals with achondroplasia35
Glucose metabolism after bariatric surgery: implications for T2DM remission and hypoglycaemia35
Metabolic control of puberty: 60 years in the footsteps of Kennedy and Mitra’s seminal work34
Programming of metabolism by adipokines during development34
Adrenal cysts: an emerging condition33
Heterogeneity and endotypes in type 1 diabetes mellitus31
Brain–immune networks: a role for GLP1 receptor31
Liver–bone crosstalk implicated in osteoporosis progression31
Revisiting the role of glucagon in health, diabetes mellitus and other metabolic diseases30
Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead30
Post-operative radioactive iodine administration in patients with low-risk thyroid cancer30
Epigenetic inheritance of polycystic ovary syndrome — challenges and opportunities for treatment30
Author Correction: Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international Consensus Statement30
Publisher Correction: Current understanding of the molecular and cellular pathology of diabetic retinopathy29
Highlights from the Joint Irish–UK Endocrine Meeting 202428
Sex differences in skeletal muscle metabolism in exercise and type 2 diabetes mellitus27
Limiting the use and misuse of liothyronine in hypothyroidism27
Type 2 diabetes mellitus in older adults: clinical considerations and management26
A perspective on treating type 1 diabetes mellitus before insulin is needed26
Author Correction: Growth hormone-releasing hormone and its analogues in health and disease26
Machine intelligence in non-invasive endocrine cancer diagnostics25
Is calorie labelling on menus the solution to obesity?25
Highlights from SfE BES 202124
Exerkines in health, resilience and disease24
Identification of genetic factors of type 2 diabetes mellitus risk in South Asian populations23
The epidemiology of type 1 diabetes mellitus in older adults22
Memory of obesity stored in adipocytes22
Exploring the functions of the myokine feimin21
Endocrinology in the multi-omics era20
The emerging evidence for non-skeletal health benefits of vitamin D supplementation in adults20
To fast or not to fast — that is the question19
Variation in metformin pharmacokinetics19
Succinate signalling regulates leptin production in adipocytes19
Syntaxin 4 — protective in β-cells in T1DM?18
A pivotal year for NAFLD and NASH therapeutics18
Exploring the regulation of glucagon secretion18
Autocrine FGF21 signalling promotes beiging18
Cause of rare form of Cushing syndrome found18
New treatment target for endometriosis18
Relugolix — new treatment for uterine fibroid-related heavy bleeding17
The importance of human brown adipose tissue volume17
Hepatic T helper 17 cells implicated in NAFLD16
The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects16
Linking liver alanine metabolism and muscle atrophy16
New combination therapy shows promise for recent-onset type 1 diabetes mellitus16
Feasibility and effectiveness of time-restricted eating in different populations15
Role for IL-17A in adipocyte biology15
Obesity phenotypes: explaining the unexplained15
Functional HNF1A variants linked with T2DM risk in European-ancestry populations14
Lipidomics reveals early markers14
Masterful papers that broke open understanding of reproductive neuroendocrinology14
Examining how our brain determines gender identity13
Brain insulin action in women13
Insulin receptor sets liver clock13
Metabolite levels during the menstrual cycle13
Late dumping syndrome or postprandial reactive hypoglycaemic syndrome after bariatric surgery13
Skeletal muscle loss and sarcopenia in obesity pharmacotherapy12
Female-specific inflammatory signalling exacerbates central nervous system autoimmunity in obesity11
One hundred years of insulin therapy11
The interactions between energy homeostasis and neurovascular plasticity11
Neurons in the diagonal band of Broca moderate food intake11
Interdisciplinary management of FGF23-related phosphate wasting syndromes: a Consensus Statement on the evaluation, diagnosis and care of patients with X-linked hypophosphataemia11
The complex effects of dietary restriction on longevity and health11
Ketosis improves muscle stem cell resilience11
Enhancing adipose tissue plasticity: progenitor cell roles in metabolic health10
The role of insufficient sleep and circadian misalignment in obesity10
Lactation duration affects obesity risk in rat offspring10
Insulin detection in diabetes mellitus: challenges and new prospects10
Optimising stem cells for diabetes mellitus therapy9
Glucagon receptor antagonists might stimulate β-cell expansion9
Antivirals in the treatment of new-onset T1DM8
Precision medicine approach improves HbA1c outcomes in T2DM8
SRC2 controls the refeeding response in mice8
Knowledge in youth is wisdom in age: involving young people in research8
Iron in adipocytes — a role in gut–adipose crosstalk8
Monogenic diabetes mellitus hidden in autoantibody-negative diabetes mellitus7
Metabolomic profiling of adrenal function in asthma7
New mechanism of Cushing disease revealed7
Engineering stem cells to recapitulate thyroid cancer7
Function of a common FTO variant in vivo7
Metformin reduces ageing adipose senescence7
Could leptin substitution therapy potentially terminate entrapment in anorexia nervosa?7
Role for exosomes in insulin sensitivity7
Diet composition affects mitochondria trafficking in adipose tissue6
Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations6
Autophagy in metabolic disease and ageing6
Applying the WHO global targets for diabetes mellitus6
Defining subpopulations of human adipose tissue progenitor cells6
Controlling brown adipose tissue size through EPAC16
Glial control of neuronal function6
Sex differences in diabetic kidney disease explained6
Negative regulator of GDF15 signalling identified6
Research in metabolic ageing — a tale of mice versus humans?6
GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease6
Detouring adrenergic stimulation to induce adipose thermogenesis5
Metabolic effects of gender-affirming hormone therapy5
How COVID-19 disrupts glycometabolic control5
Health equity in endocrinology5
PDL1 reduces adipose inflammation in obesity5
Patients’ insights into diabetes insipidus5
Opposing neuropeptides control cAMP signalling to regulate satiety5
DDIT4 contributes to macrophage reprogramming5
Handle with care — interpretation, synthesis and dissemination of data on paracetamol in pregnancy5
Probing α-cell dysfunction in type 2 diabetes mellitus5
Post-burn endocrine–immune dynamics and ageing considerations5
Dietary fructose acts on gut to increase nutrient uptake5
Advances in the management of achondroplasia5
Beyond the pancreas: contrasting cardiometabolic actions of GIP and GLP15
The effects of type 1 and type 2 diabetes mellitus on bone health in chronic kidney disease5
An integrated model of obesity pathogenesis that revisits causal direction5
Osteal macrophages implicated in osteoporosis5
Combination therapy increases human β-cell mass in vivo5
Oxytocin regulates adipose tissue lipolysis5
Genomic alterations in thyroid cancer: biological and clinical insights4
Primary aldosteronism — a multidimensional syndrome4
Environmental factors in declining human fertility4
AMPK as a mediator of tissue preservation: time for a shift in dogma?4
Skeletal disorders associated with the growth hormone–insulin-like growth factor 1 axis4
Emerging mechanisms of obesity-associated immune dysfunction4
The genetics of autoimmune Addison disease: past, present and future4
Inter-organ crosstalk during development and progression of type 2 diabetes mellitus4
Emerging therapeutic approaches for the treatment of NAFLD and type 2 diabetes mellitus4
High-intensity exercise training — too much of a good thing?4
Mammalian models of diabetes mellitus, with a focus on type 2 diabetes mellitus4
Clustering for a better prediction of type 2 diabetes mellitus4
Circulating non-coding RNA biomarkers of endocrine tumours4
The evolving functions of the vasculature in regulating adipose tissue biology in health and obesity4
Oxytocin deficiency — a ‘new’ human disorder?4
Metabolic regulation of skeletal cell fate and function4
Use of teprotumumab in thyroid eye disease3
Early life factors that affect obesity and the need for complex solutions3
Novel therapies with precision mechanisms for type 2 diabetes mellitus3
New drug target identified for β-cell dysfunction3
Pancreatic mesenchymal stem cells might protect β-cells3
Discovery of a β-cell check on insulin action3
Luteal phase support in assisted reproductive technology3
Antioxidant liver myeloid cell population identified3
GLP1 acts on an inter-organ neural circuit3
Author Correction: Optoacoustic imaging in endocrinology and metabolism3
AcroBATics: how dying brown adipocytes trigger browning3
A role for the kidney in metformin action3
A role for phosphocreatine in adipose inflammation3
Reply to: Late dumping syndrome or postprandial reactive hypoglycaemic syndrome after bariatric surgery3
Reply to ‘Tumour fibrosis in dopamine agonist-exposed prolactinomas is a diminishing concern’3
A role for HDAC6 in leptin sensitivity3
FGF1 signalling cascade suppresses lipolysis3
Consensus Statement on the definition and classification of metabolic hyperferritinaemia3
Author Correction: Consensus Statement on the definition and classification of metabolic hyperferritinaemia3
Beyond the ovary: rewiring our perspective on polycystic ovary syndrome3
Fresh insight into neonatal diabetes mutations3
GLP1–oestrogen agonist protects β-cells from insulin-deficient diabetes mellitus3
New approach to improving insulin sensitivity3
An exercise-induced metabolite alters feeding2
Adipose tissue in communication: within and without2
RalA links obesity and mitochondrial dysfunction2
Lipid and glucose metabolism in white adipocytes: pathways, dysfunction and therapeutics2
Clinical aspects of multiple endocrine neoplasia type 12
Approval of teplizumab: implications for patients2
An updated view on human neonatal thermogenesis2
Covert actions of growth hormone: fibrosis, cardiovascular diseases and cancer2
Transcriptional control of metabolism by interferon regulatory factors2
Stem-cell derived pancreatic endoderm cells in the treatment of T1DM2
New BAT–liver endocrine pathway via succinate2
Advances in incretin-based therapeutics for obesity2
Bone fragility in type 2 diabetes mellitus: a lot left to explore2
Immune dysfunction in developmental programming of type 2 diabetes mellitus2
Follistatin linked to type 2 diabetes mellitus risk2
Microbial hydrogen sulfide hampers L-cell GLP-1 production2
Role of extracellular vesicles in β-cell failure2
Dysfunctional lipid metabolism in ageing muscle: effects on glucose tolerance2
Assessment and treatment of thyroid disorders in pregnancy and the postpartum period2
Inflammation-induced adrenal dysfunction2
Macrophage and T cell networks in adipose tissue2
Debunking the myths of intermittent fasting2
Advanced neurobiological tools to interrogate metabolism2
0.96665692329407